Citadel Advisors - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 19 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$3,409,000
+3.5%
3,000,000
-5.4%
0.00%
-50.0%
Q3 2019$3,293,000
-80.5%
3,170,000
-79.1%
0.00%
-75.0%
Q2 2019$16,869,000
+25.2%
15,170,000
+16.7%
0.01%
+14.3%
Q1 2019$13,479,000
+574.6%
13,000,000
+550.0%
0.01%
+600.0%
Q4 2018$1,998,000
-75.2%
2,000,000
-71.4%
0.00%
-75.0%
Q3 2018$8,067,000
-57.9%
7,000,000
-63.7%
0.00%
-55.6%
Q2 2018$19,172,000
+22.2%
19,300,000
+14.9%
0.01%0.0%
Q1 2018$15,687,000
+27.8%
16,800,000
+6.3%
0.01%
+28.6%
Q4 2017$12,275,000
+51.7%
15,800,000
+58.0%
0.01%
+16.7%
Q3 2017$8,089,000
-40.5%
10,000,000
-42.4%
0.01%
-50.0%
Q2 2017$13,603,000
-0.1%
17,350,000
-17.8%
0.01%0.0%
Q1 2017$13,619,000
+13.4%
21,100,000
+10.5%
0.01%0.0%
Q4 2016$12,009,000
-19.1%
19,100,000
-23.6%
0.01%
-20.0%
Q3 2016$14,845,00025,000,0000.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 31,204,000$33,828,0001.01%
Opti Capital Management, LP 8,000,000$8,743,0000.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,519,000$16,885,0000.37%
CSS LLC/IL 7,007,000$7,544,0000.31%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 14,527,000$15,558,0000.28%
WOLVERINE ASSET MANAGEMENT LLC 19,454,000$20,896,0000.16%
LMR Partners LLP 9,500,000$10,292,0000.16%
Aequim Alternative Investments LP 2,000,000$2,155,0000.09%
Verition Fund Management LLC 8,091,000$8,718,0000.08%
SG Americas Securities, LLC 61,550$6,632,0000.03%
View complete list of PTC THERAPEUTICS INC shareholders